Yiping Zhang

Expert Consensus on the Diagnosis and Treatment of FGFR Gene-Altered Solid Tumors

Yu Chen, Qian Wang, Chao Zhang, 2024, Global Medical Genetics.

Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib‐refractory ALK‐positive NSCLC from a phase II study

W. Feng, K. Ma, G. Selvaggi, 2024, Cancer communications.